Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium-Reference-Cited by-同舟云学术

Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium

Published:1985-03 Issue:3 Volume:133 Page:403-407
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Sternberg Cora N.¹²³,Yagoda Alan¹²³,Scher Howard I.¹²³,Watson Robin C.¹²³,Ahmed Tauseef¹²³,Weiselberg Lora R.¹²³,Geller Nancy¹²³,Hollander Phyllis S.¹²³,Herr Harry W.¹²³,Sogani Pramod C.¹²³,Morse Michael J.¹²³,Whitmore Willet F.¹²³

Affiliation:

1. From the Solid Tumor Service, Department of Medicine, Department of Diagnostic Radiology, Biostatistics Laboratory and Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York

2. Oncology Division, North Shore University Hospital, Manhasset and Cornell University Medical College, New York, New York

3. Cornell University Medical College, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference16 articles.

1. Cis-dichlorodiammineplatinum (II) in advanced bladder cancer;Yagoda;Cancer Treat. Rep.,1976

2. Methotrexate: an active drug in bladder cancer;Natale;Cancer,1981

3. Adriamycin in advanced urinary tract cancer: experience in 42 patients and review of the literature;Yagoda;Cancer,1977

4. Phase II trial of vinblastine sulfate for metastatic urothelial tract tumors;Blumenreich;Cancer,1982

5. Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors;Schwartz;J. Urol.,1983

Cited by 564 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients;Journal of Personalized Medicine;2024-09-09

2. Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era;World Journal of Urology;2024-05-09

3. Immunotherapy for advanced or metastatic urothelial carcinoma: an abridged Cochrane review;BJU International;2024-04-24

4. Enfortumab Vedotin and Pembrolizumab — A New Perspective on Urothelial Cancer;New England Journal of Medicine;2024-03-07

5. Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using positron emission computed tomography for metastatic bladder cancer;World Journal of Clinical Cases;2023-12-26